Berisa F, McGonigle R, Beaman M, Adu D, Michael J
Queen Elizabeth Hospital, Birmingham, UK.
Diabet Med. 1989 Jan-Feb;6(1):67-70. doi: 10.1111/j.1464-5491.1989.tb01142.x.
During the 6-year period 1981-1987, 309 patients started chronic ambulatory peritoneal dialysis (CAPD), of whom 75 (24%) had diabetes. Despite severe peripheral vascular problems (20%), ischaemic heart disease (90%), and complete blindness (21%) the 1-year patient survival on CAPD was 88%. The actuarial patient survival for diabetic patients was similar to that of the non-diabetic cohort over the first 18 months but fell to 48% (compared to 70% in non-diabetic patients) at 3 years. Complications associated with CAPD, including the incidence of peritonitis, were no different between the diabetic and non-diabetic patient populations. Successful treatment for end-stage renal disease (ESRD) in diabetic patients can be achieved and justified in a liberal selection programme for the treatment of diabetic ESRD.
在1981年至1987年的6年期间，309例患者开始接受持续性非卧床腹膜透析（CAPD）治疗，其中75例（24%）患有糖尿病。尽管存在严重的外周血管问题（20%）、缺血性心脏病（90%）和完全失明（21%），但接受CAPD治疗的患者1年生存率仍为88%。糖尿病患者的精算生存率在最初18个月与非糖尿病队列相似，但在3年时降至48%（非糖尿病患者为70%）。糖尿病患者和非糖尿病患者群体中与CAPD相关的并发症，包括腹膜炎的发生率并无差异。在糖尿病终末期肾病（ESRD）的宽松选择治疗方案中，可以实现并证明对糖尿病患者进行终末期肾病的成功治疗是合理的。
